articleMolecular TherapyJan 1, 2017BRONZE OA

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

FLFrederick L. LockeSSSattva S. NeelapuNLNancy L. BartlettTSTanya SiddiqiJCJulio C. Chávez

Moffitt Cancer Center · The University of Texas MD Anderson Cancer Center · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

616
total citations
FWCI
36.72
Percentile
100%
References
35
Citations per year

Authors

16

Topics & keywords

Topics
Keywords
  • Cytokine release syndrome
  • Fludarabine
  • Medicine
  • Cyclophosphamide
  • Gastroenterology
  • Refractory (planetary science)
  • Internal medicine
  • Diffuse large B-cell lymphoma
UN Sustainable Development Goals
  • No poverty
No related works found for this paper.

Funding